Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Michael Rutledge DeBaun, MD
Healthcare Provider Director
Vanderbilt-Meharry Center for Excellence
in Sickle Cell Disease
Doctors' Office Tower, 6th Floor
2200 Children's Way
Nashville, Tennessee, United States
Michael R. DeBaun is the professor of Pediatrics, Vice Chair for clinical and translational research and the JC Peterson Endowed Chair in the Department of Pediatrics. He is a leading expert in the care of children with sickle cell disease and directs the newly established Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease. DeBaun’s research focuses on understanding cerebrovascular injury in children with sickle cell disease, and improving management of their care. His efforts also aim to better define the impact and biological mechanisms by which asthma increases sickle cell disease morbidity and mortality. He is now leading an international collaboration to develop the first longitudinal cohort of children with sickle cell anemia who have been evaluated with repeated pulmonary function tests and sleep studies.
Representative Publications:
Asthma morbidity and treatment in children with sickle cell disease
Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia
Enuresis associated with sleep disordered breathing in children with sickle cell anemia
Factors predicting future ACS episodes in children with sickle cell anemia
Related Content
-
Gaurav Kharya MBBS, DNB, DCHDr. Gaurav Kharya is a Clinical Lead at ...
-
Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospita...Introduction: Acute vaso-occlusive crisi...
-
Paula Tanabe, RN, PhDPaula Tanabe, PhD, RN, MPH, FAEN, FAAN, ...
-
Piedmont Health Services and Sickle Cell AgencyPiedmont Health Services and Sickle Cell...
-
Sickle cell patients suffer as disparities in care and research persistWhen 9-year-old Jeremy Brown is in pai...
-
GBT launches ACCEL grants program to improve access to care for people with Sickle cell diseaseGlobal Blood Therapeutics, Inc. (GBT) to...
-
Foundation For Sickle Cell Disease ResearchThe Foundation for Sickle Cell Disease R...